![]() |
市場調査レポート
商品コード
1576522
ラベルフリー検出の市場規模、シェア、予測、動向分析:製品、技術、プロセス、用途、エンドユーザー別 - 2031年までの世界の予測Label-free Detection Market Size, Share, Forecast, & Trends Analysis by Product, Technology, Process, Application, End User - Global Forecast to 2031 |
||||||
カスタマイズ可能
|
ラベルフリー検出の市場規模、シェア、予測、動向分析:製品、技術、プロセス、用途、エンドユーザー別 - 2031年までの世界の予測 |
出版日: 2024年09月01日
発行: Meticulous Research
ページ情報: 英文 320 Pages
納期: 5~7営業日
|
ラベルフリー検出市場は、2024年から2031年にかけてCAGR 9.8%で2031年までに44億8,000万米ドルに達すると予測されています。
本レポートは、広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、主要な市場促進要因、抑制要因、課題、機会の分析から構成されています。この成長は、医薬品・バイオテクノロジー市場の高成長、政府のイニシアティブ、研究開発資金の増加、創薬における革新的アプローチの採用増加によるものです。しかし、機器のコストが高く、複雑な機器を扱う熟練した専門家が不足していることが、この市場の成長を抑制しています。
さらに、ラベルフリー検出の技術進歩、PoC検査におけるラベルフリー検出の用途拡大、新興国が、この市場で事業を展開する企業に成長機会をもたらすと期待されています。しかし、低質量の低分子をリアルタイムで検出するための課題や、感度・特異度の限界が、市場成長に影響を与える大きな課題です。
(注:上位5社のSWOT分析を掲載)
Label-free Detection Market Size, Share, Forecast, & Trends Analysis by Product (Biosensor, Microplate, Microcalorimeter), Technology (SPR, BLI), Process (Binding Kinetic, Lead Generation, Hit Confirmation), Application, End User-Global Forecast to 2031
The label-free detection market is projected to reach $4.48 billion by 2031 at a CAGR of 9.8 % from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to high growth in the pharmaceutical & biotechnology market, government initiatives, rising R&D funding, and increasing adoption of innovative approaches in drug discovery. However, the high cost of instruments and shortage of skilled professionals to handle complex equipment restrain the growth of this market.
Furthermore, the technological advancements in label-free detection, growing applications of label-free detection in point-of-care testing, and emerging economies are expected to generate growth opportunities for the players operating in this market. However, the challenges of detecting low-mass small molecules in real time and limited sensitivity & specificity are major challenges impacting market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the label-free detection market are Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), GE HealthCare Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Sartorius AG (Germany), Corning Inc. (U.S.), Horiba, Ltd. (Japan), Malvern Panalytical Ltd (U.K.), and Bruker Corporation (U.S.).
Based on product type, the market is segmented into consumables, instruments, and software. Among all the instrument types, in 2024, the optical biosensor instruments segment is expected to account for the largest share of 78.4% of the label-free detection instruments market. The large market share of this segment can be attributed to the direct and real-time measurement, in addition to multiplexing capabilities, which increases its adoption.
Among all the technologies studied in this report, in 2024, the Surface Plasmon Resonance (SPR) segment is expected to account for the larger share of the label-free detection market. The large market share of this segment can be attributed to the benefits offered by the SPR technology over the other technologies, such as real-time monitoring, requires minimal amounts of sample for experiments, high sensitivity, and provides quantitative data on binding kinetics, equilibrium constants, association, and dissociation rates, and many more are the factors contributing to the significant market share of this segment.
Among all the applications studied in this report, in 2024, the drug discovery & development segment is expected to account for the largest share of the label-free detection market. Label-free detection techniques offer high-throughput screening of various drug candidates for a wide range of target molecules and offer real-time molecular interactions. This results in improved screening of massive compound databases. The capacity to quickly identify interesting lead compounds is the factor that boosts the demand for label-free detection in drug discovery.
Among all the processes studied in this report, in 2024, the binding kinetics segment is expected to account for the largest share of the label-free detection market. The large market share of this segment can be attributed to the advancements in structural biology and the growing focus on personalized medicine. Further, to ensure efficacy and safety, biologics, including monoclonal antibodies, need to be properly characterized and tested in terms of binding kinetics. Label-free detection techniques provide a non-destructive and label-free method for examining complicated interactions, which makes them an excellent alternative for biological research.
Among all the end users studied in this report, in 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the label-free detection market. The large market share of this segment can be attributed to the technological advancements that have increased the adoption of label-free technologies by the pharmaceutical & biotechnology companies, and product launches to expand the innovative offering.
An in-depth analysis of the geographical scenario of the label-free detection market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 43.6% of the label-free detection market. In the region in 2024, the U.S. is expected to account for the largest share of the label-free detection market in North America. The large share of this regional market is attributed to the presence of major label-free detection companies, increasing adoption of innovative approaches in drug discovery, and technological advancements in label-free detection technologies.
Label-free Detection Market Assessment-by Product Type
Label-free Detection Market Assessment-by Technology
Note: Other technologies include Optical Waveguide Grating Technology (OWGT), Microscale Thermophoresis (MST), and Electrical Impedance Spectroscopy (EIS).
Label-free Detection Market Assessment-by Application
Note: Other technologies include bioprocessing and impurity testing.
Label-free Detection Market Assessment-by Process
Note: Other processes include end-point screening & specificity testing and affinity analysis.
Label-free Detection Market Assessment-by End User
Label-free Detection Market Assessment-by Geography
(Note: SWOT analysis of the top 5 companies will be provided.)